Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD)
Public ClinicalTrials.gov record NCT00424528. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Two-Week, Randomized, Modified-Blind, Double-Dummy, Parallel-Group Efficacy and Safety Study of Arformoterol Tartrate Inhalation Solution Twice-Daily, Tiotropium Once-Daily, and Arformoterol Tartrate Inhalation Solution Twice-Daily and Tiotropium Once Daily in Subjects With Chronic Obstructive Pulmonary Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate and compare the efficacy of arformoterol twice a day and tiotropium once a day (dosed sequentially) versus tiotropium once a day alone in subjects with Chronic Obstructive Pulmonary Disease (COPD).
Study identification
- NCT ID
- NCT00424528
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 235 participants
Conditions and interventions
Interventions
- Arformoterol Tartrate Inhalation Solution Drug
- Tiotropium Drug
- Arformoterol and Tiotropium Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 45 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2006 (Type not available)
- Primary completion
- Oct 2007 (Actual)
- Completion
- Oct 2007 (Actual)
- Last update posted
- Jun 4, 2012
2006 – 2007
United States locations
- U.S. sites
- 28
- U.S. states
- 18
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Jasper | Alabama | 35501 | — |
| Not listed | Tucson | Arizona | 85715 | — |
| Not listed | San Diego | California | 92120 | — |
| Not listed | Colorado Springs | Colorado | 80909 | — |
| Not listed | DeFuniak Springs | Florida | 32435 | — |
| Not listed | DeLand | Florida | 32720 | — |
| Not listed | Topeka | Kansas | 66606 | — |
| Not listed | Hazard | Kentucky | 41701 | — |
| Not listed | Madisonville | Kentucky | 42431 | — |
| Not listed | Marrero | Louisiana | 70072 | — |
| Not listed | Sunset | Louisiana | 70584 | — |
| Not listed | Ann Arbor | Michigan | 48106 | — |
| Not listed | Kalamazoo | Michigan | 49007 | — |
| Not listed | Saint Charles | Missouri | 63301 | — |
| Not listed | Charlotte | North Carolina | 28207 | — |
| Not listed | Cincinnati | Ohio | 45242 | — |
| Not listed | Columbus | Ohio | 43215 | — |
| Not listed | Eugene | Oregon | 97404 | — |
| Not listed | Medford | Oregon | 97504 | — |
| Not listed | Portland | Oregon | 97213 | — |
| Not listed | East Providence | Rhode Island | 02914 | — |
| Not listed | Lincoln | Rhode Island | 02865 | — |
| Not listed | Columbia | South Carolina | 29201 | — |
| Not listed | Simpsonville | South Carolina | 29681 | — |
| Not listed | Spartanburg | South Carolina | 29303 | — |
| Not listed | Knoxville | Tennessee | 37920 | — |
| Not listed | Tacoma | Washington | 98405 | — |
| Not listed | Morgantown | West Virginia | 26505 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00424528, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 4, 2012 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00424528 live on ClinicalTrials.gov.